Applied DNA Sciences (FRA:UDJ) EV-to-EBIT : -0.05 (As of May. 13, 2024)

Applied DNA Sciences EV-to-EBIT Chart

Applied DNA Sciences Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
EV-to-EBIT		Get a 7-Day Free Trial					-1.39	-2.74	-2.70	0.05	-0.96

Applied DNA Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-0.82	-0.34	-0.65	-0.96	-0.45

Competitive Comparison of Applied DNA Sciences's EV-to-EBIT

For the Diagnostics & Research subindustry, Applied DNA Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied DNA Sciences's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's EV-to-EBIT falls into.

Applied DNA Sciences EV-to-EBIT Calculation

Applied DNA Sciences's EV-to-EBIT for today is calculated as:

Applied DNA Sciences's current Enterprise Value is €0.68 Mil.
Applied DNA Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied DNA Sciences  (FRA:UDJ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Applied DNA Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Applied DNA Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was €5.58 Mil.
Applied DNA Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied DNA Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (FRA:UDJ) Business Description